Medicare Genetic Testing Fraud Nets Prison Time and $7.2M Restitution

A Peachtree City man, Patrick Moore Jr., has been sentenced to 46 months in federal prison for his involvement in a Medicare fraud conspiracy that involved unnecessary genetic testing. Moore pleaded guilty to conspiracy to defraud the United States and will also pay over $7.2 million in restitution. Prosecutors revealed that Moore managed a network of recruiters who targeted Medicare beneficiaries to undergo genetic tests that were not medically necessary. In return for referring personal and insurance information, Moore received approximately $4.3 million in kickbacks and bribes, which he partially used to compensate the recruiters involved in the scheme. The fraudulent activity included the creation of fake invoices to hide illegal referral payments, violating the federal Anti-Kickback Statute. Laboratories linked to Moore and his co-conspirators billed Medicare roughly $24 million for these genetic tests, with Medicare ultimately disbursing around $7.2 million. The involved laboratories have not been publicly identified by federal officials. Along with his prison term, Moore will also serve three years of supervised release following incarceration. This enforcement action highlights ongoing efforts by federal authorities to combat fraud, waste, and abuse within Medicare, a significant concern in government healthcare expenditure. The case underscores the vulnerability of government programs to fraudulent schemes involving complex medical testing and recruitment networks. Healthcare compliance, particularly relating to the Anti-Kickback Statute, remains a critical focus area for providers and payers to avoid exposure to legal and financial risks. Continuous vigilance and regulatory enforcement are essential to protect Medicare funds and ensure beneficiary protections. Moore's conviction serves as a reminder of the regulatory risks associated with genetic testing referrals and the importance of stringent adherence to healthcare laws governing Medicare claims. As innovation in medical testing grows, so does the potential for fraudulent abuse, prompting ongoing regulatory scrutiny. Insurance professionals and healthcare providers must stay informed of these developments to maintain compliance and secure program integrity.